UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis

Journal of cardiovascular magnetic resonance, 2008-11, Vol.10 (1), p.54-54, Article 54

2008

Link zum Volltext

Verfügbarkeit prüfen

Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar

Journal of cardiovascular magnetic resonance, 2017-11, Vol.19 (1), p.91-91, Article 91

2017

Link zum Volltext

Verfügbarkeit prüfen

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

Journal of neurology, 2021-06, Vol.268 (6), p.2109-2122

2021

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular magnetic resonance for amyloidosis

Heart failure reviews, 2015-03, Vol.20 (2), p.133-144

2015

Link zum Volltext

Verfügbarkeit prüfen

Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome

Pediatric rheumatology online journal, 2019-07, Vol.17 (1), p.36-7, Article 36

2019

Link zum Volltext

Verfügbarkeit prüfen

Inflammatory Bowel Disease and Systemic AA Amyloidosis

Digestive diseases and sciences, 2013-06, Vol.58 (6), p.1689-1697

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

Cardiovascular drugs and therapy, 2020-06, Vol.34 (3), p.357-370

2020

Link zum Volltext

Verfügbarkeit prüfen

Hereditary auto-inflammatory disorders and biologics

Seminars in immunopathology, 2006-06, Vol.27 (4), p.494-508

2006

Link zum Volltext

Verfügbarkeit prüfen

Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker

Clinical autonomic research, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK

Advances in therapy, 2022-06, Vol.39 (6), p.2292-2301

2022

Link zum Volltext

Verfügbarkeit prüfen

Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study

Arthritis research & therapy, 2011-01, Vol.13 (6), p.R202-R202

2011

Link zum Volltext

Verfügbarkeit prüfen

Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis

Journal of cardiovascular magnetic resonance, 2013-01, Vol.15 (Suppl 1), p.O34-O34, Article O34

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literature

Arthritis research & therapy, 2013-02, Vol.15 (1), p.R30-R30

2013

Link zum Volltext

Verfügbarkeit prüfen

T1 mapping for myocardial extracellular volume measurement by cardiovascular magnetic resonance: bolus only vs primed infusion technique

Journal of cardiovascular magnetic resonance, 2013-01, Vol.15 (Suppl 1), p.O14-O14, Article O14

2013

Link zum Volltext

Verfügbarkeit prüfen

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis

Journal of cardiovascular magnetic resonance, 2012-02, Vol.14 (S1), p.O87-O87, Article O87

2012

Link zum Volltext

Verfügbarkeit prüfen

Interstitial expansion in health and disease - an equilibrium contrast CMR study

Journal of cardiovascular magnetic resonance, 2012-02, Vol.14 (S1), p.O23-O23, Article O23

2012

Link zum Volltext

Verfügbarkeit prüfen

Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

Cardiovascular drugs and therapy, 2020-12, Vol.34 (6), p.889-889

2020

Link zum Volltext

Verfügbarkeit prüfen

Equilibrium contrast CMR for the detection of amyloidosis in mice

Journal of cardiovascular magnetic resonance, 2011-02, Vol.13 (S1), p.O60-O60, Article O60

2011

Link zum Volltext

Verfügbarkeit prüfen

Developments in the scientific and clinical understanding of autoinflammatory disorders

Arthritis research & therapy, 2009-01, Vol.11 (1), p.212-212

2009

Link zum Volltext

Verfügbarkeit prüfen

Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis

Orphanet journal of rare diseases, 2015-11, Vol.10 (73), p.O21-O21

2015

Link zum Volltext

Verfügbarkeit prüfen

Methodological challenges in monitoring new treatments for rare diseases: lessons from the cryopyrin-associated periodic syndrome registry

Orphanet journal of rare diseases, 2013-09, Vol.8 (1), p.139-139, Article 139

2013

Link zum Volltext

Verfügbarkeit prüfen

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study

Orphanet journal of rare diseases, 2015-11, Vol.10 (73), p.O23-O23

2015

Link zum Volltext

Verfügbarkeit prüfen

A case report in cardiovascular magnetic resonance: the contrast agent matters in amyloid

BMC medical imaging, 2017-01, Vol.17 (1), p.3-3, Article 3

2017

Link zum Volltext

Verfügbarkeit prüfen

Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation

European journal of nuclear medicine, 1998-07, Vol.25 (7), p.709-713

1998

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

KollektionNexis Uni

KollektionSpringerLink (Online service)

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(40)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

IngentaConnect Journals
(31)
IngentaConnect Journals
(26)
EZB Electronic Journals Library
(26)
MEDLINE
(16)
Taylor & Francis:Master (3349 titles)
(14)
SpringerLINK Contemporary (Konsortium Baden-Württemberg)
(12)
Journals@Ovid Complete
(9)
Single Journals
(3)

3 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Cardiovascular magnetic resonance and prognosis in cardiac amyloidosis

Prospective comparison of novel dark blood late gadolinium enhancement with conventional bright blood imaging for the detection of scar

Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy

Cardiovascular magnetic resonance for amyloidosis

Retrospective case series describing the efficacy, safety and cost-effectiveness of a vial-sharing programme for canakinumab treatment for paediatric patients with cryopyrin-associated periodic syndrome

Inflammatory Bowel Disease and Systemic AA Amyloidosis

Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

Avoiding misdiagnosis: expert consensus recommendations for the suspicion and diagnosis of transthyretin amyloidosis for the general practitioner

Hereditary auto-inflammatory disorders and biologics

Cardiovascular autonomic failure in hereditary transthyretin amyloidosis and TTR carriers is an early and progressive disease marker

Clinical and Genetic Evaluation of People with or at Risk of Hereditary ATTR Amyloidosis: An Expert Opinion and Consensus on Best Practice in Ireland and the UK

Sustained remission of symptoms and improved health-related quality of life in patients with cryopyrin-associated periodic syndrome treated with canakinumab: results of a double-blind placebo-controlled randomized withdrawal study

Multiorgan ECV as measured by EQ-MRI in systemic amyloidosis

Clinical characteristics in subjects with NLRP3 V198M diagnosed at a single UK center and a review of the literature

T1 mapping for myocardial extracellular volume measurement by cardiovascular magnetic resonance: bolus only vs primed infusion technique

Patterns of late gadolinium enhancement in 94 patients with AL or transthyretin cardiac amyloidosis

Interstitial expansion in health and disease - an equilibrium contrast CMR study

Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

Equilibrium contrast CMR for the detection of amyloidosis in mice

Developments in the scientific and clinical understanding of autoinflammatory disorders

Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis

Methodological challenges in monitoring new treatments for rare diseases: lessons from the cryopyrin-associated periodic syndrome registry

Diflunisal therapy for cardiac ATTR amyloidosis: a longitudinal, prospective, single centre study

A case report in cardiovascular magnetic resonance: the contrast agent matters in amyloid

Serum amyloid P component scintigraphy in familial amyloid polyneuropathy: regression of visceral amyloid following liver transplantation

Aktive Filter

Suchergebnisse filtern